US Patent Issued to Scribe Therapeutics on April 7 for "Compositions and methods for the targeting of PCSK9" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,349, issued on April 7, was assigned to Scribe Therapeutics Inc. (Alameda, Calif.).

"Compositions and methods for the targeting of PCSK9" was invented by Jason Fernandes (Redwood City, Calif.), Sean Higgins (Alameda, Calif.), Sarah Denny (San Francisco), Ross White (Concord, Calif.), Emeric Jean Marius Charles (Berkeley, Calif.), Addison Wright (El Cerrito, Calif.), Benjamin Demaree (Berkeley, Calif.) and Benjamin Oakes (El Cerrito, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are gene repressor systems comprising fusion proteins, such as fusion proteins comprising a DNA binding domain such as a TALE, zinc finger or catalyti...